Published in Healthcare Mergers, Acquisitions and Ventures Week, February 16th, 2008
CAT is a leading agro-biotechnology company listed on OTCBB in Dec 2007 (BULLETIN BOARD: CAGTF) . The company reported total audited revenues of US$37 million in fiscal year ended 30 September 2007, with gross profits of US$35 million and net income of US$32 million. CAT promotes ecologically sustainable technology to meet the global demands for biofuel supply and helps address environmental needs.
Mr. Cantonnet is a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week